Literature DB >> 8600761

Dengue encephalitis: a true entity?

L C Lum1, S K Lam, Y S Choy, R George, F Harun.   

Abstract

Involvement of the central nervous system in dengue fever and dengue hemorrhagic fever has always been thought to be secondary to vasculitis with resultant fluid extravasation, cerebral edema, hypoperfusion, hyponatremia, liver failure, and/or renal failure. Thus, the condition has been referred to as dengue encephalopathy. Encephalitis or direct involvement of the brain by the virus was thought to be unlikely. This paper reports on six children who were seen over a period of two years presenting on the second or third day of illness with dengue encephalitis. The diagnosis was based upon a clinical picture of encephalitis and confirmed by cerebrospinal fluid (CSF) microscopy and electroencephalography changes. All six cases were confirmed dengue infections. Dengue 3 virus was isolated from the CSF of four cases and in one case, dengue 2 was detected by the polymerase chain reaction in both the CSF and blood. In the sixth case, virologic evidence was negative but dengue immunoglobulin M was detected in the CSF and blood. Since the onset of encephalitis appears early in the course of illness coinciding with the viremic phase, we postulate that the virus crosses the blood-brain barrier and directly invades the brain causing encephalitis. This study provides strong evidence that dengue 2 and 3 viruses have neurovirulent properties and behave similarly to other members of the Flaviviridae.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600761     DOI: 10.4269/ajtmh.1996.54.256

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  61 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Dengue encephalitis with predominant cerebellar involvement: report of eight cases with MR and CT imaging features.

Authors:  Vinay Hegde; Zarina Aziz; Sharath Kumar; Maya Bhat; Chandrajit Prasad; A K Gupta; M Netravathi; Jitender Saini
Journal:  Eur Radiol       Date:  2014-11-01       Impact factor: 5.315

Review 3.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

4.  The pathogenesis of spinal cord involvement in dengue virus infection.

Authors:  Jing An; De-Shan Zhou; Kazunori Kawasaki; Kotaro Yasui
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

Review 5.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

Review 6.  Emergence of the severe syndrome and mortality associated with dengue and dengue-like illness: historical records (1890 to 1950) and their compatibility with current hypotheses on the shift of disease manifestation.

Authors:  Goro Kuno
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

7.  Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication.

Authors:  Jeffrey E McLean; Aleksandra Wudzinska; Emmanuel Datan; Daniela Quaglino; Zahra Zakeri
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

8.  Atypical manifestations of dengue fever.

Authors:  Arti Pawaria; Devendra Mishra; Monica Juneja; Jagdish Meena
Journal:  Indian Pediatr       Date:  2014-06       Impact factor: 1.411

9.  Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Authors:  F Guirakhoo; K Pugachev; Z Zhang; G Myers; I Levenbook; K Draper; J Lang; S Ocran; F Mitchell; M Parsons; N Brown; S Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; R Nichols; D Trent; T Monath
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Co-infections with chikungunya virus and dengue virus in Delhi, India.

Authors:  Harendra S Chahar; Preeti Bharaj; Lalit Dar; Randeep Guleria; Sushil K Kabra; Shobha Broor
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.